ADAPTIMMUNE THERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 0.90% for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2020-02-27
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2019 was 0.90%, a 21.74% decline from fiscal 2018.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2018 was 1.15%, a 51.32% increase from fiscal 2017.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2017 was 0.76%, a 28.97% decline from fiscal 2016.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2016 was 1.07%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|
| 2019-12-31 | 0.90% 10-K · filed 2020-02-27 | ||
| 2018-12-31 | 1.15% 10-K · filed 2020-02-27 | ||
| 2017-12-31 | 0.76% 10-K · filed 2019-02-27 | ||
| 2016-12-31 | 1.07% 10-K · filed 2019-02-27 | ||
| 2016-09-30 | 1.07% 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | 1.07% 10-Q · filed 2016-08-08 | ||
| 2015-09-30 | 1.39% 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | 1.39% 10-Q · filed 2016-08-08 | 1.54% 10-K · filed 2018-03-15 |